HCA
HCA Healthcare, Inc.
NYSE · Healthcare · Medical - Care Facilities · US
$458.84
−2.06%Next report
Analyst consensus
- Next report date
- Oct 27, 2026
- EPS estimate
- $6.70
- Revenue estimate
- $19.4B
Latest reported
- Last report date
- Jul 24, 2026
- EPS actual
- $7.59
- EPS estimate
- $7.58
- Revenue actual
- $20.2B
- Revenue estimate
- $19.8B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 3
- Avg surprise (4Q)
- +7.0%
- Revenue beats (12Q)
- 6
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $458
- PT range
- $380 – $579
- Analysts
- 15
10 Buy4 Hold1 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 24, 2026 | $7.58 | $7.59 | Beat 0.15% | $20.2B |
| Apr 24, 2026 | $7.14 | $7.15 | Beat 0.17% | $19.1B |
| Jan 27, 2026 | $7.46 | $8.01 | Beat 7.40% | $19.5B |
| Oct 24, 2025 | $5.79 | $6.96 | Beat 20.21% | $19.2B |
| Jul 25, 2025 | $6.29 | $6.84 | Beat 8.74% | $18.6B |
| Apr 25, 2025 | $5.75 | $6.45 | Beat 12.17% | $18.3B |
| Jan 24, 2025 | $6.13 | $6.22 | Beat 1.47% | $18.3B |
| Oct 25, 2024 | $4.99 | $5.03 | Beat 0.80% | $17.5B |
| Jul 23, 2024 | $4.85 | $5.53 | Beat 14.02% | $17.5B |
| Apr 26, 2024 | $5.01 | $5.93 | Beat 18.36% | $17.3B |
| Jan 30, 2024 | $5.06 | $5.93 | Beat 17.19% | $17.3B |
| Jul 27, 2023 | $4.22 | $4.29 | Beat 1.63% | $15.9B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 27, 2026